Enfortumab vedotin intravenous infusion used to treat advanced bladder cancer
Contains enfortumab vedotin 20 mg, an antibody-drug conjugate that targets and destroys cancer cells expressing Nectin-4, used to treat advanced or metastatic urothelial (bladder) cancer.
Attributes
Product Content
How to Use:
• Administered only by a doctor or nurse by intravenous infusion in a hospital setting.
• Dose and schedule are decided by your oncologist.
• Report skin reactions, numbness or vision changes to your doctor.
• Prescription medicine; take exactly as prescribed and consult your doctor before use.
The link to Padcev E.V. 20 mg 1 Vial (Refrigerated) has been copied